The Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder(III): Pharmacologic Treatment
Journal of the Korean Academy of Child and Adolescent Psychiatry
;
: 16-25, 2007.
Article
in Korean
| WPRIM
| ID: wpr-154566
ABSTRACT
The objective of this review is to propose the Korean practice guideline for pharmacological treatment of attentiondeficit hyperactivity disorder(ADHD). For making the guideline, the authors used the evidence-base approaches derived from a detailed review of literature including wide range of controlled clinical trials, studies of side effects of drugs, toxicological reports, and meta-analyses published in United States and Europe, as well as inside Korea. The review committee composed of experts in ADHD in Korea has reviewed the parameter. The practice parameter for pharmacological treatment describes the use of stimulants, atomoxetine, modafinil, bupropion, tricyclic antidepressants, and alpha-adrenergic agonists and their side effects. The recommendations of pharmacological treatment are proposed at the end of the article.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
United States
/
Bupropion
/
Adrenergic alpha-Agonists
/
Advisory Committees
/
Europe
/
Atomoxetine Hydrochloride
/
Korea
/
Antidepressive Agents, Tricyclic
Type of study:
Practice guideline
Country/Region as subject:
North America
/
Asia
/
Europa
Language:
Korean
Journal:
Journal of the Korean Academy of Child and Adolescent Psychiatry
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS